DRAY

NASDAQ

Macondray Capital Acquisition Corp. I

IPO2021

$16.23-0.40 (-2.41%)

News23/Ratings0

Macondray Capital Acquisition Corp. I intends to effect a merger or mergers, amalgamation, share exchange, share purchase, asset acquisition, reorganization, or similar business combination with one or more businesses. It intends to focus on companies in the software, data and technology, media, and telecom industries. The company was incorporated in 2021 and is based in Woodside, California.

Price$16.23-12.26 (-43.03%)

2026-01-212026-04-24

Latest news

23 items

284dPR
YieldMax® Introduces Option Income Strategy ETF on DraftKings, Inc. (DKNG)
CHICAGO and MILWAUKEE and NEW YORK, July 15, 2025 (GLOBE NEWSWIRE) -- YieldMax® announced the launch today of the following ETF: YieldMax® DKNG Option Income Strategy ETF (NYSE:DRAY) DRAY seeks to generate current income by pursuing options-based strategies on DraftKings, Inc. ("DKNG"). DRAY is managed by Tidal Financial Group. DRAY does not invest directly in DKNG. DRAY is the newest member of the YieldMax® ETF family and like all YieldMax® ETFs, aims to deliver current income to investors. With respect to distributions, DRAY will be a Group C ETF, and its first distribution is expected to be announced on August 20, 2025. Please see the table below for distribution information for
1166d13D/G
SEC Form SC 13G/A filed by Macondray Capital Acquisition Corp. I (Amendment)
SC 13G/A - Macondray Capital Acquisition Corp. I (0001852771) (Subject)
1180d13D/G
SEC Form SC 13G/A filed by Macondray Capital Acquisition Corp. I (Amendment)
SC 13G/A - Macondray Capital Acquisition Corp. I (0001852771) (Subject)
1194dSEC
SEC Form 15-12G filed by Macondray Capital Acquisition Corp. I
15-12G - Macondray Capital Acquisition Corp. I (0001852771) (Filer)
1205dSEC
SEC Form 25-NSE filed by Macondray Capital Acquisition Corp. I
25-NSE - Macondray Capital Acquisition Corp. I (0001852771) (Subject)
1214dSEC
Macondray Capital Acquisition Corp. I filed SEC Form 8-K: Other Events, Financial Statements and Exhibits (Amendment)
8-K/A - Macondray Capital Acquisition Corp. I (0001852771) (Filer)
1215dSEC
Macondray Capital Acquisition Corp. I filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
8-K - Macondray Capital Acquisition Corp. I (0001852771) (Filer)
1215dNEWS
Macondray Capital Acquisition Corp. I Announces It Will Redeem Its Public Shares And Will Not Consummate An Initial Business Combination
Macondray Capital Acquisition Corp. I (NASDAQ:DRAY) (the "Company") announced today that, because the Company will not consummate an initial business combination within the time period required by its Second Amended and Restated Memorandum and Articles of Association (the "Amended Articles"), the Company intends to liquidate and dissolve in accordance with the provisions of the Amended Articles, effective as of the close of business on January 6, 2023, and will redeem all of the outstanding Class A ordinary shares that were included in the units issued in its initial public offering (the "Public Shares"), at an anticipated per-share redemption price of approximately $10.00. As of the close
1215dPR
Macondray Capital Acquisition Corp. I Announces it will Redeem its Public Shares and will not Consummate an Initial Business Combination
Macondray Capital Acquisition Corp. I (NASDAQ:DRAY) (the "Company") announced today that, because the Company will not consummate an initial business combination within the time period required by its Second Amended and Restated Memorandum and Articles of Association (the "Amended Articles"), the Company intends to liquidate and dissolve in accordance with the provisions of the Amended Articles, effective as of the close of business on January 6, 2023, and will redeem all of the outstanding Class A ordinary shares that were included in the units issued in its initial public offering (the "Public Shares"), at an anticipated per-share redemption price of approximately $10.00. As of the close
1263dSEC
SEC Form 10-Q filed by Macondray Capital Acquisition Corp. I
10-Q - Macondray Capital Acquisition Corp. I (0001852771) (Filer)
1352dSEC
SEC Form 10-Q filed by Macondray Capital Acquisition Corp. I
10-Q - Macondray Capital Acquisition Corp. I (0001852771) (Filer)
1471dSEC
SEC Form 10-K filed by Macondray Capital Acquisition Corp. I
10-K - Macondray Capital Acquisition Corp. I (0001852771) (Filer)
1474d13D/G
SEC Form SC 13G filed by Macondray Capital Acquisition Corp. I
SC 13G - Macondray Capital Acquisition Corp. I (0001852771) (Subject)
1486dSEC
SEC Form NT 10-K filed by Macondray Capital Acquisition Corp. I
NT 10-K - Macondray Capital Acquisition Corp. I (0001852771) (Filer)
1531d13D/G
SEC Form SC 13G/A filed by Macondray Capital Acquisition Corp. I (Amendment)
SC 13G/A - Macondray Capital Acquisition Corp. I (0001852771) (Subject)
1535d13D/G
SEC Form SC 13G filed by Macondray Capital Acquisition Corp. I
SC 13G - Macondray Capital Acquisition Corp. I (0001852771) (Subject)
1536d13D/G
SEC Form SC 13G/A filed by Macondray Capital Acquisition Corp. I (Amendment)
SC 13G/A - Macondray Capital Acquisition Corp. I (0001852771) (Subject)
1541d13D/G
SEC Form SC 13G filed by Macondray Capital Acquisition Corp. I
SC 13G - Macondray Capital Acquisition Corp. I (0001852771) (Subject)
1557dNEWS
Dare Bioscience Shares Up 0.6%; Brookline Capital Markets Initiates With Buy Rating; $6 Price Target
1611d13D/G
SEC Form SC 13G filed by Macondray Capital Acquisition Corp. I
SC 13G - Macondray Capital Acquisition Corp. I (0001852771) (Subject)
1615dSEC
SEC Form 10-Q filed by Macondray Capital Acquisition Corp. I
10-Q - Macondray Capital Acquisition Corp. I (0001852771) (Filer)
1615dSEC
Macondray Capital Acquisition Corp. I filed SEC Form 8-K: Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
8-K - Macondray Capital Acquisition Corp. I (0001852771) (Filer)
1621dSEC
SEC Form NT 10-Q filed by Macondray Capital Acquisition Corp. I
NT 10-Q - Macondray Capital Acquisition Corp. I (0001852771) (Filer)